GSK Investigational Site

Newtown, Wellington 6021

0 studies enrolling now · 2 studies all time

What they study most

Melanoma, Pulmonary Disease, Chronic Obstructive

Studies at this site

• A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma — Completed